FDAnews Drug Daily Bulletin

Critical Pharmaceuticals Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone

Feb. 13, 2013
A A
Critical Pharmaceuticals today announced that it has successfully completed a second clinical study on its CP024 growth hormone nasal spray.
PipelineReview